Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...

to proceed with Phase 1 clinical trials in the United States for its drug candidate CLN-978, targeting systemic lupus erythematosus (SLE), a chronic autoimmune disease. The clearance allows the ...

HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral ...

to proceed with Phase 1 clinical trials in the United States for its drug candidate CLN-978, targeting systemic lupus erythematosus (SLE), a chronic autoimmune disease. The clearance allows the ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

In spite of considerable achievements, treatment of established lupus is a difficult task. Complete remission of mild disease with mucocutaneus or joint disease remains a challenge with a ...

In this difficult clinical situation ... on limited evidence Prevent damage Minimize both damage due to systemic lupus erythematosus and as consequence of medications, particularly glucocorticoids ...

"We are honored to welcome Alison to the Artiva Board of Directors. Her decades of executive experience in manufacturing and ...

The increasing prevalence of autoimmune and immune-mediated diseases (AIMDs) underscores the need to understand environmental ...